News and Updates
Stay up to date with news about primary immunodeficiency disorders and the ImmUnity Canada community.
Update on Canadian Blood Services News
In response to recent news items, we would like to state that regarding the rumours of Canadian Blood Services and the possibility of the announcement of an impending deal with a plasma manufacturer: The Canadian...
New CIPO Strategic Plan
CIPO has been undergoing a strategic planning exercise and are happy to announce our new Strategic Plan 2022-2027. Our goals and objectives for the next three to five years will focus on sustainability, strong programming,...
New Research Opportunities
Three research studies are currently recruiting from members of the immunodeficiency community. Please see below for more details: Primary immunodeficiency patients who have been diagnosed with IgA sensitivity may be eligible to...
CIPO AGM and Board Elections
AGM The Canadian Immunodeficiencies Patient Organization (CIPO) 2022 Annual General Meeting will take place virtually Saturday, October 1st at 4pm EST (1pm PST). All CIPO members are entitled to attend and vote at the AGM....
New CIPO Bylaws
CIPO's Board of Directors and Governance Committee have reviewed and re-drafted the organizational bylaws given the input from our membership. The bylaws will be voted on at the AGM on October 1, 2022. Please send any comments...
CIPO Scholarship Awards Open
CIPO is excited to announce the first ever higher education scholarship application open. These scholarships are open to youth 17-25 who are currently enrolled or accepted at a recognized Canadian higher education institution...
CIPO Immunology Resident Research Grant applications open
CIPO is pleased applications are now open for the CIPO Immunology Resident Research Grant in honour of our 25th anniversary. Up to two residents will be awarded, pending the complexity of proposed study. The maximum award pool...
CIPO Study Published
CIPO's COVID-19 study that looked at vaccine hestitancy in PI patients has been published in the journal for Allergy, Asthma and Immunology. We are pleased to have supported this research and be taking part in important...